BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11844681)

  • 21. Dual antagonists of platelet activating factor and histamine. Identification of structural requirements for dual activity of N-Acyl-4-(5,6-dihydro-11H-benzo [5,6]cyclohepta-[1,2-b]pyridin-11-ylidene)piperidines.
    Piwinski JJ; Wong JK; Green MJ; Ganguly AK; Billah MM; West RE; Kreutner W
    J Med Chem; 1991 Jan; 34(1):457-61. PubMed ID: 1671420
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis of N,N'-disubstituted 3-aminobenzo[c] and [d]azepin-2-ones as potent and specific farnesyl transferase inhibitors.
    Le Diguarher T; Ortuno JC; Shanks D; Guilbaud N; Pierré A; Raimbaud E; Fauchère JL; Hickman JA; Tucker GC; Casara PJ
    Bioorg Med Chem Lett; 2004 Feb; 14(3):767-71. PubMed ID: 14741286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of a novel series of farnesyl protein transferase inhibitors as non-peptidic CAAX tetrapeptide analogues.
    Perez M; Maraval C; Dumond S; Lamothe M; Schambel P; Etiévant C; Hill B
    Bioorg Med Chem Lett; 2003 Apr; 13(8):1455-8. PubMed ID: 12668011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sch-66336 (sarasar) and other benzocycloheptapyridyl farnesyl protein transferase inhibitors: discovery, biology and clinical observations.
    Taveras AG; Kirschmeier P; Baum CM
    Curr Top Med Chem; 2003; 3(10):1103-14. PubMed ID: 12769711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent and selective farnesyl transferase inhibitors.
    Millet R; Domarkas J; Houssin R; Gilleron P; Goossens JF; Chavatte P; Logé C; Pommery N; Pommery J; Hénichart JP
    J Med Chem; 2004 Dec; 47(27):6812-20. PubMed ID: 15615530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diaryl ether inhibitors of farnesyl-protein transferase.
    Mactough SC; Desolms SJ; Shaw AW; Abrams MT; Ciccarone TM; Davide JP; Hamilton KA; Hutchinson JH; Koblan KS; Kohl NE; Lobell RB; Robinson RG; Graham SL
    Bioorg Med Chem Lett; 2001 May; 11(10):1257-60. PubMed ID: 11392531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Farnesyl-derived inhibitors of ras farnesyl transferase.
    Kang MS; Stemerick DM; Zwolshen JH; Harry BS; Sunkara PS; Harrison BL
    Biochem Biophys Res Commun; 1995 Dec; 217(1):245-9. PubMed ID: 8526918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substituted azoloquinolines and -quinazolines as new potent farnesyl protein transferase inhibitors.
    Angibaud P; Bourdrez X; End DW; Freyne E; Janicot M; Lezouret P; Ligny Y; Mannens G; Damsch S; Mevellec L; Meyer C; Muller P; Pilatte I; Poncelet V; Roux B; Smets G; Van Dun J; Van Remoortere P; Venet M; Wouters W
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4365-9. PubMed ID: 14643327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-Arylindole-3-acetamides: FPP-competitive inhibitors of farnesyl protein transferase.
    Trotter BW; Quigley AG; Lumma WC; Sisko JT; Walsh ES; Hamann CS; Robinson RG; Bhimnathwala H; Kolodin DG; Zheng W; Buser CA; Huber HE; Lobell RB; Kohl NE; Williams TM; Graham SL; Dinsmore CJ
    Bioorg Med Chem Lett; 2001 Apr; 11(7):865-9. PubMed ID: 11294379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of 7-substituted farnesyl diphosphate analogues.
    Rawat DS; Gibbs RA
    Org Lett; 2002 Sep; 4(18):3027-30. PubMed ID: 12201708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent, selective, and orally bioavailable tricyclic pyridyl acetamide N-oxide inhibitors of farnesyl protein transferase with enhanced in vivo antitumor activity.
    Njoroge FG; Vibulbhan B; Pinto P; Bishop WR; Bryant MS; Nomeir AA; Lin C; Liu M; Doll RJ; Girijavallabhan V; Ganguly AK
    J Med Chem; 1998 May; 41(10):1561-7. PubMed ID: 9572881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stable analogues of geranylgeranyl diphosphate possessing improved geranylgeranyl versus farnesyl protein transferase inhibitory selectivity.
    Minutolo F; Bertini S; Betti L; Danesi R; Gervasi G; Giannaccini G; Papi C; Placanica G; Barontini S; Rapposelli S; Macchia M
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4405-8. PubMed ID: 14643335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of 2,4,6-trisubstituted N-arylsulfonyl piperidines as gamma-secretase inhibitors.
    Li H; Asberom T; Bara TA; Clader JW; Greenlee WJ; Josien HB; McBriar MD; Nomeir A; Pissarnitski DA; Rajagopalan M; Xu R; Zhao Z; Song L; Zhang L
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6290-4. PubMed ID: 17890085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of novel SCD1 inhibitors: 5-alkyl-4,5-dihydro-3H-spiro[1,5-benzoxazepine-2,4'-piperidine] analogs.
    Uto Y; Ueno Y; Kiyotsuka Y; Miyazawa Y; Kurata H; Ogata T; Takagi T; Wakimoto S; Ohsumi J
    Eur J Med Chem; 2011 May; 46(5):1892-6. PubMed ID: 21356569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Farnesyl protein transferase inhibitors as potential cancer chemopreventives.
    Kelloff GJ; Lubet RA; Fay JR; Steele VE; Boone CW; Crowell JA; Sigman CC
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):267-82. PubMed ID: 9107432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New class of azaheptapyridine FPT inhibitors as potential cancer therapy agents.
    Zhu HY; Desai J; Cooper AB; Wang J; Rane DF; Kirschmeier P; Strickland C; Liu M; Nomeir AA; Girijavallabhan VM
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1228-31. PubMed ID: 24462667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Three dimensional quantitative structure-activity relationship of farnesyl protein transferase inhibitors].
    Wan SB; Yi X; Guo ZR
    Yao Xue Xue Bao; 2001 Jun; 36(6):423-6. PubMed ID: 12585125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational considerations in the design of dual antagonists of platelet-activating factor (PAF) and histamine.
    Kaminski JJ; Carruthers NI; Wong SC; Chan TM; Billah MM; Tozzi S; McPhail AT
    Bioorg Med Chem; 1999 Jul; 7(7):1413-23. PubMed ID: 10465415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solid-phase synthesis of novel inhibitors of farnesyl transferase.
    Barber AM; Hardcastle IR; Rowlands MG; Nutley BP; Marriott JH; Jarman M
    Bioorg Med Chem Lett; 1999 Feb; 9(4):623-6. PubMed ID: 10098677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-thiol 3-aminomethylbenzamide inhibitors of farnesyl-protein transferase.
    Ciccarone TM; MacTough SC; Williams TM; Dinsmore CJ; O'Neill TJ; Shah D; Culberson JC; Koblan KS; Kohl NE; Gibbs JB; Oliff AI; Graham SL; Hartman GD
    Bioorg Med Chem Lett; 1999 Jul; 9(14):1991-6. PubMed ID: 10450968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.